Drug application
SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE (MAGNESIUM SULFATE, POTASSIUM SULFATE, SODIUM SULFATE)
Drugs@FDA ANDA 206431 · TARO
Key facts
| Drug name | SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE |
|---|---|
| Active ingredients | MAGNESIUM SULFATE, POTASSIUM SULFATE, SODIUM SULFATE |
| Application type | ANDA |
| Application number | 206431 |
| Company | TARO |
| Dosage forms | SOLUTION, ORAL |
| Strength | 1.6GM/BOT;3.13GM/BOT;17.5GM/BOT |
| Marketing status | Prescription |
| TE codes | AA |
| Reference listed drug | No |
| Latest submission status date | Mar 19, 2024 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- 1–9 Therapeutic equivalents
- Yes FDA letters on file
- No FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: